Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee approves Board of Pharmacy rule rewrite but strikes labeling subsections after compounding debate
Summary
The Senate Health and Welfare Committee approved a comprehensive rewrite of the Idaho State Board of Pharmacy rules but voted to remove two labeling subsections after stakeholders raised concerns about compounding and an unsettled FDA draft guidance.
The Senate Health and Welfare Committee on Jan. 14 approved a pending rewrite of the Idaho State Board of Pharmacy rules (docket 24-3601-2402) while removing two labeling subsections related to distribution of compounded products.
The committee’s action follows a presentation from Nikki Chopsky, bureau chief for Health Professions at the Division of Occupational and Professional Licenses, who said the board conducted multiple public meetings and stakeholder negotiations as part of a zero‑based review (ZBR) that produced more than 35 changes to the chapter. The changes consolidate definitions, remove duplicative language that has been moved to statute following last year’s House Bill 527, and reorganize licensure, practice standards, compounding, controlled substances and prescription monitoring rules.
Why it matters: The removed subsections concern…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
